C
Claudio Chiesa
Researcher at National Research Council
Publications - 147
Citations - 5864
Claudio Chiesa is an academic researcher from National Research Council. The author has contributed to research in topics: Nonalcoholic fatty liver disease & Insulin resistance. The author has an hindex of 39, co-authored 145 publications receiving 5091 citations. Previous affiliations of Claudio Chiesa include Sapienza University of Rome.
Papers
More filters
Journal ArticleDOI
Reliability of Procalcitonin Concentrations for the Diagnosis of Sepsis in Critically Ill Neonates
Claudio Chiesa,Alessandra Panero,Naila Rossi,M. Stegagno,Maria De Giusti,John Frederick Osborn,Lucia Pacifico +6 more
TL;DR: Procalcitonin is a promising marker for the diagnosis of early- and late-onset sepsis in neonates at high risk for this infection.
Journal ArticleDOI
C-Reactive Protein, Interleukin-6, and Procalcitonin in the Immediate Postnatal Period: Influence of Illness Severity, Risk Status, Antenatal and Perinatal Complications, and Infection
Claudio Chiesa,Gabriella Pellegrini,Alessandra Panero,John Frederick Osborn,Fabrizio Signore,Marcello Assumma,Lucia Pacifico +6 more
TL;DR: Early-onset neonatal infection was associated with significant increases in CRP, IL-6, and PCT concentrations at all three time points, independent of illness severity, but among babies without infection, higher SNAP and SNAP-PE scores were associated with higher IL- 6 concentrations at birth.
Journal ArticleDOI
Diagnosis of Neonatal Sepsis: A Clinical and Laboratory Challenge
Claudio Chiesa,Alessandra Panero,John Frederick Osborn,Antonella F. Simonetti,Lucia Pacifico +4 more
TL;DR: The evaluation of tests for neonatal sepsis is important because the infection may present a very serious threat to the baby and the result of a diagnostic test must be evaluated in the light of the clinical condition of the baby.
Journal ArticleDOI
Sarcopenia and nonalcoholic fatty liver disease: a causal relationship.
TL;DR: NAFLD, particularly its histological phenotype non-alcoholic steatohepatitis (NASH), can progress to advanced liver disease, cirrhosis and hepatocellular carcinoma and indication for liver transplantation.
Journal ArticleDOI
C reactive protein and procalcitonin: reference intervals for preterm and term newborns during the early neonatal period.
Claudio Chiesa,Fabio Natale,Roberto Pascone,John Osborn,Lucia Pacifico,Lucia Pacifico,Enea Bonci,Mario De Curtis +7 more
TL;DR: Age- and GA-specific reference ranges for both CRP and PCT should be taken into account to optimize their use in the diagnosis of early-onset neonatal sepsis.